摘要
[通用名称]alefacept
[理化性状]本品为一种重组人融合蛋白,相对分子质量为91.4×103道尔顿.白色或灰白色、无菌、无防腐剂的注射用冻干粉针剂,加入0.5mL无菌注射用水后成为清澈透明溶液,pH值约为6.9.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2003年第11期954-955,共2页
Chinese Journal of New Drugs
参考文献3
-
1[1]Bos JD,Hagenaars C,Das PK,et al. Predominance of "memory"T cells (CD4+ ,CDw29 + ) over "naive" T cells (CD4 + ,CD45R+ ) in both normal and diseased human skin[J]. Arch Dernatol Res, 1989, (281): 24 - 30.
-
2[2]Ellis C, Krueger GG. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes[J]. N Engl J Med, 2001, (345): 248 - 255.
-
3[4]Nick J, Lowe MD, Gonzalez J, et al. Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy[J]. Int J Dermatol,2003,3(42) :224 - 230.
同被引文献15
-
1丁鼎乐.抗牛皮癣新药Raptiva与依坦西普将在欧洲争夺市场[J].上海医药,2005,26(1):38-38. 被引量：1
-
2马培奇.04035 硫鸟嘌呤能够清除顽固性牛皮癣[J].国外药讯,2001(4):17-17. 被引量：1
-
3马培奇.05045 Remicade治疗牛皮癣有效[J].国外药讯,2001(5):18-19. 被引量：1
-
4吴绍熙,郭宁如.Clinical Observation on Effect of Triptolide Tablet in Treating Patients with Psoriasis Vulgaris[J].Chinese Journal of Integrated Traditional and Western Medicine,2005,11(2):147-148. 被引量：10
-
5Majeau GR,Meier W,Jimmo B,et al.Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses.Structure/function analysis in vitro and in human CD2 transgenic mice[J].J Immunol,1994,152(6):2753-2767.
-
6Berzofsky JA,Berkower IJ.Fundamental Immunology[M].In Paul We ed.Raven New York,1984:595-644.
-
7Majeau GR,Whitty A,Yim K,et al.Low affinity binding of an LFA-3/IgG1 fusion protein to CD2^+ T cells is independent of cell activation[J].Cell Adhes Commun,1999,7(3):267-279.
-
8Devrimci-Ozguven H,Kundakci TN,Kumbasar H,et al.The depression,anxiety,life satisfaction and affective expression levels in psoriasis patients[J].J Eur Acad Dermatol Venereol,2000,14(4):267-271.
-
9Gupta MA,Gupta AK.Depression and suicidal ideation in dermatology patients with acne,alopecia areata,atopic dermatitis and psoriasis[J].Br J Dermatol,1998,139(5):846-850.
-
10Rapp SR,Exum ML,Reboussin DM,et al.The physical,psychological and social impact of psoriasis[J].J Health Psychol,1997,2:535-537.
引证文献2
-
1林碧蓉,谈珉,李晶,王海华,薛静亚,华军,柏莹瑛,寇庚,钱卫珠,侯盛,王皓.重组人LFA3-Ig融和蛋白体内外生物活性研究[J].现代免疫学,2006,26(5):357-361. 被引量：1
-
2孙爱军,王荣,贾正平.银屑病的药物治疗[J].第四军医大学学报,2007,28(21):2014-2015. 被引量：1
二级引证文献2
-
1Xian-ping LI,Jing LI,Heng YAN,Sheng HOU,Wei-zhu QIAN,Yong-chuan CHEN,Min TANG,Bo-hua LI,Da-peng ZHANG,Bo ZHOU,Hao WANG,Fei HAO,Ya-jun GUO.Pharmacokinetic and pharmacodynamic study of LFA3Ig fusion protein in healthy volunteers and patients with psoriasis[J].Acta Pharmacologica Sinica,2008,29(9):1077-1085.
-
2卢传坚,闫玉红,赵瑞芝.银屑灵片对鼠尾鳞片表皮颗粒层形成的影响[J].中药新药与临床药理,2010,21(3):231-233. 被引量：17
-
1刘萍,边强.Alefacept[J].中国新药杂志,2004,13(2):180-181.
-
2王铮.FDA批准alefacept用于牛皮癣[J].国外药讯,2003(5):33-33.
-
3张燕.Amevive对牛皮癣性关节炎有效[J].国外药讯,2005(6):28-28.
-
4吴萍（摘）.Astellas即将研发用于移植的alefacept联合治疗[J].国外药讯,2008(4):32-33.
-
5章鸣.09038 Biogen提出Amevive的美国NDA[J].国外药讯,2001(9):17-17.
-
6张黎,易军,臧林泉,黄婧莹,张凤玲.靶向性抗肺癌新药ZP-1在不同溶液中的稳定性研究[J].广东药学院学报,2015,31(1):1-4.
-
7Ortonne J.P.,Khemis A.,Koo J.,Choi J.,周少娜.Alefacept与UVB联合治疗慢性斑块型银屑病:一项开放标记式研究[J].世界核心医学期刊文摘（皮肤病学分册）,2006,0(5):14-15.
-
8孙国山,郝京生,陈崇智.抗凝血酶Ⅲ若干研究进展[J].国外医药（合成药．生化药．制剂分册）,1991,12(6):328-330.
-
9Menter A.,Cather J.C.,Baker D.,李晓莉.多疗程alefacept治疗中重度慢性斑块型银屑病患者的疗效[J].世界核心医学期刊文摘（皮肤病学分册）,2006,0(4):5-5.
-
10黄俐俐.Biogen的Amevive加光疗[J].国外药讯,2003(4):20-20.
